Lynch TH - Search Results

1

Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?

Walsh AL, Tuzova AV, Bolton EM, Lynch TH, Perry AS. Walsh AL, et al. Among authors: lynch th. Trends Mol Med. 2014 Aug;20(8):428-36. doi: 10.1016/j.molmed.2014.03.005. Epub 2014 May 13. Trends Mol Med. 2014. PMID: 24836411 Review.

2

Noncoding RNAs in prostate cancer: the long and the short of it.

Bolton EM, Tuzova AV, Walsh AL, Lynch T, Perry AS. Bolton EM, et al. Clin Cancer Res. 2014 Jan 1;20(1):35-43. doi: 10.1158/1078-0432.CCR-13-1989. Epub 2013 Oct 21. Clin Cancer Res. 2014. PMID: 24146262 Review.

3

In silico analysis and DHPLC screening strategy identifies novel apoptotic gene targets of aberrant promoter hypermethylation in prostate cancer.

Murphy TM, Sullivan L, Lane C, O'Connor L, Barrett C, Hollywood D, Lynch T, Lawler M, Perry AS. Murphy TM, et al. Prostate. 2011 Jan 1;71(1):1-17. doi: 10.1002/pros.21212. Prostate. 2011. PMID: 20564325

4

IGFBP7 promoter methylation and gene expression analysis in prostate cancer.

Sullivan L, Murphy TM, Barrett C, Loftus B, Thornhill J, Lawler M, Hollywood D, Lynch T, Perry AS. Sullivan L, et al. J Urol. 2012 Oct;188(4):1354-60. doi: 10.1016/j.juro.2012.06.002. Epub 2012 Aug 17. J Urol. 2012. PMID: 22906661

5

Manipulating the epigenome for the treatment of urological malignancies.

O'Rourke CJ, Knabben V, Bolton E, Moran D, Lynch T, Hollywood D, Perry AS. O'Rourke CJ, et al. Pharmacol Ther. 2013 May;138(2):185-96. doi: 10.1016/j.pharmthera.2013.01.007. Epub 2013 Jan 24. Pharmacol Ther. 2013. PMID: 23353098 Free PMC article. Review.

6

Are all gonadotrophin-releasing hormone agonists equivalent for the treatment of prostate cancer? A systematic review.

Bolton EM, Lynch T. Bolton EM, et al. BJU Int. 2018 Sep;122(3):371-383. doi: 10.1111/bju.14168. Epub 2018 May 8. BJU Int. 2018. PMID: 29438592

7

MicroRNAs as putative mediators of treatment response in prostate cancer.

O'Kelly F, Marignol L, Meunier A, Lynch TH, Perry AS, Hollywood D. O'Kelly F, et al. Among authors: lynch th. Nat Rev Urol. 2012 May 22;9(7):397-407. doi: 10.1038/nrurol.2012.104. Nat Rev Urol. 2012. PMID: 22613932 Review.

8

Gene expression analysis in prostate cancer: the importance of the endogenous control.

Vajda A, Marignol L, Barrett C, Madden SF, Lynch TH, Hollywood D, Perry AS. Vajda A, et al. Among authors: lynch th. Prostate. 2013 Mar;73(4):382-90. doi: 10.1002/pros.22578. Epub 2012 Aug 27. Prostate. 2013. PMID: 22926970

9

Impact of warm ischaemia time during partial nephrectomy on renal function - is it really a matter of time?

Bolton EM, Lynch TH. Bolton EM, et al. Among authors: lynch th. BJU Int. 2018 Jan;121(1):3-4. doi: 10.1111/bju.14085. BJU Int. 2018. PMID: 29314540 No abstract available.

10

In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer.

Perry AS, Loftus B, Moroose R, Lynch TH, Hollywood D, Watson RW, Woodson K, Lawler M. Perry AS, et al. Among authors: lynch th. Br J Cancer. 2007 May 21;96(10):1587-94. doi: 10.1038/sj.bjc.6603767. Epub 2007 Apr 24. Br J Cancer. 2007. PMID: 17453001 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters